Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-021502
Filing Date
2024-08-16
Accepted
2024-08-16 18:16:36
Documents
2
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 form3-08162024_100833.html 3  
1 form3-08162024_100833.xml 3 1710
2 ex24-08162024_100833.htm EX-24 8708
  Complete submission text file 0001415889-24-021502.txt   12038
Mailing Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065
Business Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Issuer) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063
Business Address
Bir Dawn Carter (Reporting) CIK: 0001688712 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36593 | Film No.: 241217853